Skip to main content

Cyteir Therapeutics, Inc.

CYTDelisted Mar 18, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001662244

Cyteir Therapeutics, Inc. was delisted on Mar 18, 2024; its insiders filed their last Form 4 on Mar 25, 2024; 38 institutions reported holding it in 13F filings for Q4 2023, worth $38.9M in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Cyteir Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
52
+4 vs. Q4 2021
Shares held
22.2M
−132.6K (−0.6%) vs. Q4 2021
Total value
$83.8M
−$169.6M (−66.9%) vs. Q4 2021
New holders
13
21 more added
Sold out
9
9 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CYT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 52 institutions
Q1 2021: 0 institutionsQ2 2021: 33 institutionsQ3 2021: 38 institutionsQ4 2021: 48 institutionsQ1 2022: 52 institutionsQ2 2022: 45 institutionsQ3 2022: 37 institutionsQ4 2022: 30 institutionsQ1 2023: 32 institutionsQ2 2023: 39 institutionsQ3 2023: 41 institutionsQ4 2023: 38 institutionsQ1 2024: 4 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $83.8M
Q1 2021: $0Q2 2021: $352.6MQ3 2021: $344.1MQ4 2021: $253.4MQ1 2022: $83.8MQ2 2022: $56.8MQ3 2022: $34.6MQ4 2022: $28.5MQ1 2023: $23.9MQ2 2023: $41.7MQ3 2023: $46.3MQ4 2023: $38.9MQ1 2024: $11.2MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CYT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20244$11.2M
Q4 202338$38.9M
Q3 202341$46.3M
Q2 202339$41.7M
Q1 202332$23.9M
Q4 202230$28.5M
Q3 202237$34.6M
Q2 202245$56.8M
Q1 202252$83.8M
Q4 202148$253.4M
Q3 202138$344.1M
Q2 202133$352.6M
Q1 20210$0

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Cyteir Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding CYT in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Novo Holdings A/S4,840,413$18.2M0.96%00.0%Unchanged
FMR LLC4,501,233$17.0M0.00%+452,240+11.2%Added
Ra Capital Management, L.P.3,350,506$12.6M0.28%00.0%Unchanged
OUP Management Co., LLC2,474,572$9.33M7.10%00.0%Unchanged
Avidity Partners Management LP1,850,000$6.97M0.15%+4620.0%Added
Janus Henderson Group PLC1,719,610$6.49M0.00%−152,811−8.2%Reduced
Baker Bros. Advisors LP812,640$3.06M0.02%00.0%Unchanged
BlackRock Inc.664,746$2.51M0.00%+122,324+22.6%Added
Vanguard Group Inc384,953$1.45M0.00%+41,720+12.2%Added
Geode Capital Management, LLC226,249$852.0K0.00%+88,089+63.8%Added
Morgan Stanley159,350$600.0K0.00%+72,159+82.8%Added
Millennium Management LLC155,087$585.0K0.00%+103,227+199.0%Added
Evercore Wealth Management, LLC146,676$553.0K0.01%+146,676New
Northern Trust Corp138,244$521.0K0.00%+65,819+90.9%Added
State Street Corp136,510$515.0K0.00%+21,702+18.9%Added
Caas Capital Management LP105,091$396.0K0.07%−372,419−78.0%Reduced
Renaissance Technologies LLC97,800$369.0K0.00%+71,600+273.3%Added
D. E. Shaw & Co., Inc.71,859$271.0K0.00%+48,146+203.0%Added
Citadel Advisors LLC42,746$162.0K0.00%+42,746New
Charles Schwab Investment Management Inc41,838$158.0K0.00%+19,111+84.1%Added
UBS Group AG31,681$120.0K0.00%−2,930−8.5%Reduced
Parametric Portfolio Associates LLC27,924$105.0K0.00%+27,924New
Bank of New York Mellon Corp25,005$94.0K0.00%+7,855+45.8%Added
Bank of America Corp24,230$92.0K0.00%+8,886+57.9%Added
Jump Financial, LLC21,300$80.0K0.00%+21,300New
Two Sigma Investments, LP18,393$69.0K0.00%+18,393New
ACT Capital Management, LLC15,000$57.0K0.06%00.0%Unchanged
Goldman Sachs Group Inc13,797$52.0K0.00%+1,660+13.7%Added
JPMorgan Chase & Co12,937$49.0K0.00%+6,616+104.7%Added
Nuveen Asset Management, LLC10,992$48.0K0.00%00.0%Unchanged
Rhumbline Advisers12,555$47.0K0.00%+12,555New
Cubist Systematic Strategies, LLC12,573$47.0K0.00%+12,573New
Centiva Capital, LP11,856$45.0K0.00%+11,856New
American International Group, Inc.9,273$35.0K0.00%+4,830+108.7%Added
California State Teachers Retirement System7,860$30.0K0.00%+3,342+74.0%Added
New York State Common Retirement Fund5,978$23.0K0.00%+7+0.1%Added
Deutsche Bank AG4,476$17.0K0.00%−606−11.9%Reduced
Tower Research Capital LLC (TRC)4,558$17.0K0.00%+2,380+109.3%Added
Wells Fargo & Company3,561$13.0K0.00%−875−19.7%Reduced
Barclays PLC3,034$12.0K0.00%+3,034New
Allspring Global Investments Holdings, LLC2,868$10.0K0.00%−573−16.7%Reduced
Steward Partners Investment Advisory, LLC2,200$8.00K0.00%−1,000−31.3%Reduced
Legal & General Group Plc2,122$8.00K0.00%+1,340+171.4%Added
STRS Ohio1,900$7.00K0.00%00.0%Unchanged
Citigroup Inc1,480$6.00K0.00%−1,663−52.9%Reduced
Amalgamated Bank1,232$5.00K0.00%+1,232New
Amalgamated Financial Corp.1,232$5.00K0.00%+1,232New
Royal Bank of Canada1,147$4.00K0.00%−1,054−47.9%Reduced
Ameritas Investment Partners, Inc.641$2.00K0.00%00.0%Unchanged
Point72 Hong Kong Ltd231$1.00K0.00%+231New
Daiwa Securities Group Inc.103$00.00%00.0%Unchanged
Meeder Asset Management Inc3$00.00%+3New
Acuta Capital Partners, LLC0$00.00%−391,974−100.0%Sold out
Ally Bridge Group (NY) LLC0$00.00%−319,538−100.0%Sold out
Sofinnova Investments, Inc.0$00.00%−179,450−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−98,860−100.0%Sold out
Gyon Technologies Capital Management, LP0$00.00%−22,345−100.0%Sold out
Jane Street Group, LLC0$00.00%−15,843−100.0%Sold out
Ergoteles LLC0$00.00%−13,355−100.0%Sold out
High Net Worth Advisory Group LLC0$00.00%−500−100.0%Sold out
State of Wyoming0$00.00%−44−100.0%Sold out